- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Extended Home Hemodialysis Improves Survival Outcomes Than In-Center Hemodialysis
A recent study published in the Kidney International Reports found that extended home hemodialysis (HHD) significantly improves the survival rates and overall outcomes of patients compared to in-center hemodialysis (ICHD). This discovery is set to revolutionize the way we approach treatment for patients with kidney disease.
More frequent and longer hemodialysis sessions have long been associated with better clinical outcomes for patients on dialysis. However, the adoption of home-based treatments like HHD has been limited on a global scale. This study aimed to address the gap by comparing thrice-weekly extended HHD with ICHD in a large patient population with a long-term follow-up.
The study, which included 349 patients starting HHD between 2010 and 2014, matched with 1047 concurrent patients on ICHD using propensity scores. Patients were followed up from their respective baselines until September 30, 2018.
The primary outcome was overall survival. Secondary outcomes included technique survival, hospitalization rates, and changes in clinical, laboratory, and medication parameters.
Key findings from the study revealed that HHD had a remarkable 40% lower risk for all-cause mortality compared to ICHD. The all-cause mortality rate was 3.76 per 100 patient-years in the HHD group, in stark contrast to 6.27 per 100 patient-years in the ICHD group.
Moreover, the technical survival rate for HHD was an impressive 86.5% over five years, affirming its effectiveness and long-term viability as a treatment option. Patients on HHD also benefited from better control of phosphate and blood pressure, improved nutrition, reduced inflammation, fewer days of hospitalization, and decreased medication requirements.
These results have substantial implications for the field of kidney disease treatment. Extended HHD not only offers better survival prospects but also significantly enhances the overall quality of life for patients. Furthermore, the cost-effectiveness and flexibility of home-based treatments like HHD make it a compelling option for healthcare providers and patients alike.
Reference:
Ok, E., Demirci, C., Asci, G., Yuksel, K., Kircelli, F., Koc, S. K., Mahsereci, E., Odabas, A. R., Stuard, S., Maddux, F. W., Raimann, J. G., Kotanko, P., Sezis, M., … Keleş, M. (2023). Patient Survival With Extended Home Hemodialysis Compared to In-center Conventional Hemodialysis. In Kidney International Reports. Elsevier BV. https://doi.org/10.1016/j.ekir.2023.09.007
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751